Newer developments in the treatment of Gram-positive infections
Gram-positive organisms are continually a major cause of infection. These organisms are ever-evolving and exhibit resistance to nearly all available agents. Historically, vancomycin was crowned the drug of choice for many of these organisms including methicillin-resistant Staphylococcus aureus, peni...
Saved in:
Main Authors: | Pornpan Koomanachai, Jared L. Crandon, David P. Nicolau |
---|---|
Other Authors: | Hartford Hospital |
Format: | Review |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/27852 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Pharmacodynamic modeling of intravenous antibiotics against gram-negative bacteria collected in the United States
by: Pornpan Koomanachai, et al.
Published: (2018) -
Pharmacodynamic profile of tigecycline against methicillin-resistant Staphylococcus aureus in an experimental pneumonia model
by: Pornpan Koomanachai, et al.
Published: (2018) -
Pharmacodynamic evaluation of tigecycline against Acinetobacter baumannii in a murine pneumonia model
by: Pornpan Koomanachai, et al.
Published: (2018) -
In vitro pharmacodynamics of simulated pulmonary exposures of tigecycline alone and in combination against Klebsiella pneumoniae isolates producing a KPC carbapenemase
by: Dora E. Wiskirchen, et al.
Published: (2018) -
Effectiveness and safety of polymyxin B for the treatment of infections caused by extensively drug-resistant gram-negative bacteria in Thailand
by: Thundon Ngamprasertchai, et al.
Published: (2019)